Adverse Event Clinical Research
1.0.1 - STU1 International flag

This page is part of the Adverse Event Clinical Research (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions

: Medication Request for bresentrik - JSON Representation

Page standards status: Informative

Raw json | Download


{
  "resourceType" : "MedicationRequest",
  "id" : "medicationrequest-for-bresentrik",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationRequest</b><a name=\"medicationrequest-for-bresentrik\"> </a><a name=\"hcmedicationrequest-for-bresentrik\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationRequest &quot;medicationrequest-for-bresentrik&quot; </p></div><p><b>identifier</b>: <code>http://www.bmc.nl/portal/medstatements</code>/1234568900-studyDrug\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>intent</b>: order</p><h3>Medications</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Reference</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"Medication-bresentrik.html\">Medication/bresentrik: bresentrik 2mg tablet</a></td></tr></table><p><b>subject</b>: <a href=\"Patient-JanetPatient.html\">Patient/JanetPatient: Janet</a> &quot; CLINICAL TRIAL PATIENT&quot;</p><p><b>supportingInformation</b>: <a href=\"ResearchStudy-BreastCancerTrial.html\">ResearchStudy/BreastCancerTrial: http://baseUrlOfHospitalHolding/PlanDefinition/protocol-for-the-ResearchStudy</a></p><p><b>authoredOn</b>: 2023-04-05</p><p><b>requester</b>: <span>: Could be reference to inline contained profile such as Reference(practitioner-1) Ronald Bone, MD</span></p><h3>Reasons</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>Breast Cancer <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#254837009)</span></td></tr></table><blockquote><p><b>dosageInstruction</b></p><p><b>sequence</b>: 1</p><p><b>text</b>: 6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count.  With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL</p><p><b>timing</b>: Once per 1 days</p><p><b>route</b>: Oral route (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#26643006)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote></blockquote><blockquote><p><b>dispenseRequest</b></p><p><b>numberOfRepeatsAllowed</b>: 1</p><p><b>quantity</b>: 600 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span></p><h3>ExpectedSupplyDurations</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Value</b></td><td><b>Unit</b></td><td><b>System</b></td><td><b>Code</b></td></tr><tr><td style=\"display: none\">*</td><td>30</td><td>days</td><td><a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-ucum.html\">Unified Code for Units of Measure (UCUM)</a></td><td>d</td></tr></table></blockquote></div>"
  },
  "identifier" : [
    {
      "use" : "official",
      "system" : "http://www.bmc.nl/portal/medstatements",
      "value" : "1234568900-studyDrug"
    }
  ],
  "status" : "active",
  "intent" : "order",
  "medication" : {
    "reference" : {
      🔗 "reference" : "Medication/bresentrik",
      "display" : "bresentrik 2mg tablet"
    }
  },
  "subject" : {
    🔗 "reference" : "Patient/JanetPatient",
    "display" : "Janet"
  },
  "supportingInformation" : [
    {
      🔗 "reference" : "ResearchStudy/BreastCancerTrial",
      "display" : "http://baseUrlOfHospitalHolding/PlanDefinition/protocol-for-the-ResearchStudy"
    }
  ],
  "authoredOn" : "2023-04-05",
  "requester" : {
    "display" : "Could be reference to inline contained profile such as Reference(practitioner-1) Ronald Bone, MD"
  },
  "reason" : [
    {
      "concept" : {
        "coding" : [
          {
            "system" : "http://snomed.info/sct",
            "code" : "254837009",
            "display" : "Breast Cancer"
          }
        ]
      }
    }
  ],
  "dosageInstruction" : [
    {
      "sequence" : 1,
      "text" : "6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count.  With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL",
      "timing" : {
        "repeat" : {
          "frequency" : 1,
          "period" : 1,
          "periodUnit" : "d"
        }
      },
      "route" : {
        "coding" : [
          {
            "system" : "http://snomed.info/sct",
            "code" : "26643006",
            "display" : "Oral route (qualifier value)"
          }
        ]
      },
      "doseAndRate" : [
        {
          "type" : {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/dose-rate-type",
                "code" : "ordered",
                "display" : "Ordered"
              }
            ]
          },
          "doseQuantity" : {
            "value" : 6,
            "unit" : "mg",
            "system" : "http://unitsofmeasure.org",
            "code" : "mg"
          }
        }
      ]
    }
  ],
  "dispenseRequest" : {
    "numberOfRepeatsAllowed" : 1,
    "quantity" : {
      "value" : 600,
      "unit" : "mg",
      "system" : "http://unitsofmeasure.org",
      "code" : "mg"
    },
    "expectedSupplyDuration" : {
      "value" : 30,
      "unit" : "days",
      "system" : "http://unitsofmeasure.org",
      "code" : "d"
    }
  }
}